Erste Asset Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33,600
| Closed | -$2.65M | – | 786 |
|
|
2024
Q2 | $2.65M | Hold |
33,600
| – | – | 0.04% | 282 |
|
|
2024
Q1 | $2.3M | Hold |
33,600
| – | – | 0.03% | 289 |
|
|
2023
Q4 | $2.13M | Buy |
33,600
+4,600
| +16% | +$291K | 0.03% | 292 |
|
|
2023
Q3 | $1.46M | Hold |
29,000
| – | – | 0.03% | 304 |
|
|
2023
Q2 | $1.41M | Hold |
29,000
| – | – | 0.02% | 322 |
|
|
2023
Q1 | $1.05M | Hold |
29,000
| – | – | 0.02% | 359 |
|
|
2022
Q4 | $1.38M | Buy |
29,000
+14,800
| +104% | +$702K | 0.03% | 312 |
|
|
2022
Q3 | $352K | Hold |
14,200
| – | – | 0.01% | 457 |
|
|
2022
Q2 | $294K | Hold |
14,200
| – | – | 0.01% | 481 |
|
|
2022
Q1 | $342K | Hold |
14,200
| – | – | 0.01% | 466 |
|
|
2021
Q4 | $341K | Hold |
14,200
| – | – | 0.01% | 464 |
|
|
2021
Q3 | $366K | Hold |
14,200
| – | – | 0.01% | 443 |
|
|
2021
Q2 | $321K | Hold |
14,200
| – | – | 0.01% | 447 |
|
|
2021
Q1 | $265K | Hold |
14,200
| – | – | 0.01% | 435 |
|
|
2020
Q4 | $398K | Buy |
+14,200
| New | +$398K | 0.01% | 409 |
|